about
Activation of galanin receptor 2 stimulates large conductance Ca(2+)-dependent K(+) (BK) channels through the IP3 pathway in human embryonic kidney (HEK293) cellsAnxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalizationA neuropeptide Y variant (rs16139) associated with major depressive disorder in replicate samples from Chinese Han population.Localization of choline acetyltransferase in rat peripheral sympathetic neurons and its coexistence with nitric oxide synthase and neuropeptides.Neuropeptides--an overview.Suppressed kindling epileptogenesis in mice with ectopic overexpression of galaninAssociation of galanin and major depressive disorder in the Chinese Han population.Galanin overexpressing transgenic mice.Physiology of quantal norepinephrine release from somatodendritic sites of neurons in locus coeruleus.Electrophysiological studies on galanin effects in brain--progress during the last six years.Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).Postendocytotic traffic of the galanin R1 receptor: a lysosomal signal motif on the cytoplasmic terminusElectrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neuronsRegulation of G protein-coupled receptor trafficking.Localization of neuropeptide Y Y1 receptors in cerebral blood vesselsPhospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain.On the release of glutamate and aspartate in the basal ganglia of the rat: interactions with monoamines and neuropeptides.Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain.Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion.Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas.Expression and function of vascular endothelial growth inhibitor in aged porcine bladder detrusor muscle cells.Plasma galanin is a biomarker for severity of major depressive disorder.Lack of association between dendritic cell nuclear protein-1 gene and major depressive disorder in the Han Chinese population.Expression of galanin and nitric oxide synthase in subpopulations of serotonin neurons of the rat dorsal raphe nucleus.Galanin receptor 2 overexpressing mice display an antidepressive-like phenotype: possible involvement of the subiculum.Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via D1-subtype of receptor.Involvement of TL1A and DR3 in induction of ischaemia and inflammation in urinary bladder dysfunction in the elderly.Ca2+/calmodulin-dependent protein kinase type IV in dorsal root ganglion: colocalization with peptides, axonal transport and effect of axotomyGalanin Protects Rat Cortical Astrocyte from Oxidative Stress: Involvement of GalR2 and pERK1/2 Signal Pathway.Dorsal column inhibition of nociceptive thalamic cells mediated by gamma-aminobutyric acid mechanisms in the catNitric oxide synthase and cGMP in the anterior pituitary gland: effect of a GnRH antagonist and nitric oxide donorsExpression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localizationNeuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous systemRegulation of expression of galanin and galanin receptors in dorsal root ganglia and spinal cord after axotomy and inflammationNPY Receptor 2 Mediates NPY Antidepressant Effect in the mPFC of LPS Rat by Suppressing NLRP3 Signaling Pathway
P50
Q24338754-BA3D2239-4F2D-4ABD-926E-451AD78A7604Q24537645-BF09566D-EA4A-45AB-BEF1-A6ADB8CF2A22Q28575154-3B7B5781-A05D-419D-883B-455BF33035F8Q30457617-6AF5B56B-BE1B-4C03-A336-BA9D6B6A7058Q33726250-136160CD-B117-4C09-9870-36B42C02D8BEQ33922451-EB3C4552-0BC4-4F3B-A6B4-4BFEA677DFB3Q33950287-825C6827-320F-4E4E-AC4D-23D2EE6BB82FQ34760592-F1C7980C-96EA-4FC0-B2FC-A9783E6855FEQ34930490-D5C19876-15A7-47D5-A544-53399BDF45D8Q35807313-E3F655BA-7C65-431F-9301-0FE97908267AQ36156104-4406C4C0-FA99-4379-9C85-6070909E82DDQ36497519-5F411569-6DCB-4690-B6AB-A6E340D04D58Q36535543-8D1B63C0-E8DD-48E4-ABE6-B2E37B020FD6Q36749642-DE63A695-4A8F-423F-8681-ED81BFEA5CA3Q36788569-25416D9E-01A3-47B9-9CFA-6AD3ACFE92D8Q36828324-35E6DD66-C8EA-430E-9DC8-BDD992C6E9E5Q37018810-0F448EC2-EEC5-4AED-9A1F-9681A4DF1CD9Q41509296-C117C038-0A40-43D4-89EF-8E6FD39DA6B3Q42999997-7D3D87AE-3A90-490F-B2E3-913090AA272EQ44340257-C67CC7C5-0DF2-4B47-B054-580FA92A13ABQ44926164-0D45DAA0-D330-47FD-870A-4580EDA08E10Q45826100-4AF8C90C-2E90-46C4-AAD0-8944FFD4BABCQ48179516-946DEA86-76D1-4B35-9CEC-74089F59FFDDQ48482064-74F578BF-1CC6-4404-8B53-16B2D393FC6DQ48641736-47B53D92-09C3-4BCD-B988-2124A79CEC9DQ48851655-8F60F857-1693-45CF-AE94-121F4825DA88Q48933548-17CE4DE9-2AB4-4C31-8EC4-A9BDFFDEA3CDQ54307837-057EC0A8-AE28-4031-B469-6E7E96541B25Q57990463-7E293434-62F1-4A63-8C5D-FD162CA56BADQ64986975-68173D2C-EA92-4891-9E66-5EC809F9C0AFQ72581918-1BCF703A-3C09-401E-8586-D0B5C0FF1B38Q73150243-E166421F-EB8A-48FE-B8D5-0C43705D06D1Q74179318-56627EAD-8360-4169-AD93-4D2CED2BF402Q74746823-87451766-4F49-4C20-B279-075761265D37Q77935374-75B27C00-05F2-4B8A-A296-DB1B9687848BQ91315884-18B00836-56CE-410A-A2EB-00D0242FFBD9
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-0387-7559
@en
name
Zhi-Qing David Xu
@ast
Zhi-Qing David Xu
@en
Zhi-Qing David Xu
@nl
type
label
Zhi-Qing David Xu
@ast
Zhi-Qing David Xu
@en
Zhi-Qing David Xu
@nl
prefLabel
Zhi-Qing David Xu
@ast
Zhi-Qing David Xu
@en
Zhi-Qing David Xu
@nl
P106
P21
P31
P496
0000-0002-0387-7559